WHO director-general Tedros Adhanom Ghebreyesus. Photo: Fabrice Coffrini/AFP via Getty Images

The World Health Organization will resume its hydroxychloroquine trial after its safety committee found "there are no reasons to modify the trial protocol," WHO's director-general Tedros Adhanom Ghebreyesus said at a press briefing Wednesday.

The big picture: The organization temporarily suspended its trial for the antimalarial drug last week after an analysis published in The Lancet showed coronavirus patients who took hydroxychloroquine or its related drug chloroquine were more likely to die or develop an irregular heart rhythm.

  • The medical journal said Wednesday an independent audit was issued after scientific questions were raised Tuesday by the New England Journal of Medicine regarding how the data was collected and reported in the paper.
  • The database of nearly 100,000 patients from Chicago company Surgisphere was used in two studies published in The Lancet and the NEJM.

By the numbers: More than 3,500 patients worldwide have been recruited for the WHO trial, which is reviewing four medicines as potential treatments for COVID-19.

"The Data Safety and Monitoring Committee will continue to closely monitor the safety of all therapeutics being tested in the Solidarity Trial. ... WHO is committed to accelerating the development of effective therapeutics, vaccines and diagnostics as part of our commitment to serving the world with science, solutions and solidarity."
— Tedros Adhanom Ghebreyesus

Still, Tedros stressed the health organization is only studying the drug and is in no way endorsing its usage beyond clinical trials.

Go deeper

2 hours ago - Health

Cash can't fix the economy's problems until the coronavirus is curbed

Illustration: Sarah Grillo/Axios

There's plenty of money. It's just not moving to where it's needed.

Driving the news: Thursday's jobs report showed 4.8 million jobs created in June, but those were overwhelmingly people beginning to return to places where they had been temporarily laid off. The number of "permanent job losers" went up, not down, rising 25% in just one month to 2.8 million from 2.2 million.

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 1 p.m. ET: 10,742,416 — Total deaths: 517,162 — Total recoveries — 5,515,076Map.
  2. U.S.: Total confirmed cases as of 1 p.m. ET: 2,699,658 — Total deaths: 128,184 — Total recoveries: 729,994 — Total tested: 32,827,359Map.
  3. States: Florida reports more than 10,000 new coronavirus cases — 5 states saw 27% spike in heart-related deaths in first 3 months of coronavirus pandemic.
  4. Federal government: Coronavirus testing czar: "We are not flattening the curve right now"
  5. Sports: 9 more NBA players test positive for coronavirus.

Coronavirus testing czar: "We are not flattening the curve right now"

Adm. Brett Giroir, the Health and Human Services official overseeing the nation's coronavirus testing efforts, told Congress Thursday that the U.S. is "not flattening the curve right now," and that the nationwide surge in new cases is not simply a result of more testing.

Why it matters: President Trump said at a press conference just hours earlier that the U.S. is getting the coronavirus "under control." He and other top members of his administration have sought to downplay the growing surge in infections as largely a product of increased testing.